Literature DB >> 4228833

Drug treatment in 117 cases of Huntington's disease with special reference to fluphenazine (Prolixin).

C Korenyi, J R Whittier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4228833     DOI： 10.1007/bf01573339

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN： 0033-2720


× No keyword cloud information.
  5 in total

1.  SYMPTOMATIC CONTROL OF SYDENHAM'S CHOREA.

Authors:  H D KURLAND
Journal:  Int J Neuropsychiatry       Date:  1965 Mar-Apr

2.  Drug use-rate in a state hospital.

Authors:  J R WHITTIER; C D KORENYI; O DIAMOND; P J TOMLINSON; H A LABURT
Journal:  Am J Psychiatry       Date:  1959-08       Impact factor: 18.112

3.  [A short examination for aphasia].

Authors:  H SCHUELL
Journal:  Neurology       Date:  1957-09       Impact factor: 9.910

4.  Effect of imipramine (Tofranil) on depression and hyperkinesia in Huntington's disease.

Authors:  J WHITTIER; G HAYDU; J CRAWFORD
Journal:  Am J Psychiatry       Date:  1961-07       Impact factor: 18.112

5.  The treatment of Huntington's chorea with trifluoperazine (Stelazine).

Authors:  N H COHEN
Journal:  J Nerv Ment Dis       Date:  1962-01       Impact factor: 2.254
  5 in total
  5 in total

1.  The battered-child syndrome: parental motivation, clinical aspects.

Authors:  G V Laury
Journal:  Bull N Y Acad Med       Date:  1970-09

Review 2.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

3.  Effect of climatic temperature on the age of onset of Huntington's chorea.

Authors:  C J Brackenridge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

Review 4.  Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.

Authors:  Thirunavukkarasu Velusamy; Archana S Panneerselvam; Meera Purushottam; Muthuswamy Anusuyadevi; Pramod Kumar Pal; Sanjeev Jain; Musthafa Mohamed Essa; Gilles J Guillemin; Mahesh Kandasamy
Journal:  Oxid Med Cell Longev       Date:  2017-01-12       Impact factor: 6.543

5.  International Guidelines for the Treatment of Huntington's Disease.

Authors:  Anne-Catherine Bachoud-Lévi; Joaquim Ferreira; Renaud Massart; Katia Youssov; Anne Rosser; Monica Busse; David Craufurd; Ralf Reilmann; Giuseppe De Michele; Daniela Rae; Ferdinando Squitieri; Klaus Seppi; Charles Perrine; Clarisse Scherer-Gagou; Olivier Audrey; Christophe Verny; Jean-Marc Burgunder
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.086
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.